J&J Units Hit Mylan With IP Suit Over Concerta Generic Bid
Two Johnson & Johnson units filed a patent suit against drugmaker Mylan Inc. in Delaware federal court on Monday, alleging Mylan's bid to market a generic version of the Concerta attention-deficit...To view the full article, register now.
Already a subscriber? Click here to view full article